Buy Monsanto (MON) Given the Large Arb Spread - BMO

October 6, 2016 8:21 AM EDT
Get Alerts MON Hot Sheet
Price: $108.58 +0.43%

Rating Summary:
    21 Buy, 11 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade MON Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

BMO Capital analyst Joel Jackson is recommending investors buy Monsanto (NYSE: MON) given large merger spread/

Jackson commented, "F2017/18E (Aug) estimates lower ~5% following MON's FQ4 release. Though handicapping the Bayer/MON regulatory process remains complicated, we continue to see the asymmetrically positive risk/reward as compelling. The EU could rule on ChemChina/Syngenta in late October with an approval likely narrowing the currently wide 24% discount to MON's $128 takeout price. On a standalone basis, MON could have upside from current levels ($105-110/sh) assuming an ~18x ~$5.50-6.00 mid-term EPS run-rate plus the $2 billion reverse break fee. We continue to rate MON Outperform with a $128 target price."

The firm maintained an Outperform rating and price target of $128 on MON.

For an analyst ratings summary and ratings history on Monsanto click here. For more ratings news on Monsanto click here.

Shares of Monsanto closed at $103.18 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Mergers and Acquisitions, Trader Talk

Related Entities

BMO Capital, Definitive Agreement

Add Your Comment